The Supreme Court said Wednesday it will consider whether to restrict access to a widely used abortion drug β even in states where the procedure is still allowed.
The case concerns the drug mifepristone that β when coupled with another drug β is one of the most common abortion methods in the United States.
The decision means the conservative-leaning court will again wade into the abortion debate after overturning Roe v. Wade last year, altering the landscape of abortion rights nationwide and triggering more than half the states to outlaw or severely restrict the procedure.